Calumet Specialty Ownership
| CLMT Stock | USD 18.66 0.15 0.81% |
Shares in Circulation | First Issued 2005-09-30 | Previous Quarter 86.4 M | Current Value 86.8 M | Avarage Shares Outstanding 61.4 M | Quarterly Volatility 21.9 M |
Calumet Stock Ownership Analysis
About 22.0% of the company shares are held by company insiders. The company has Price/Earnings To Growth (PEG) ratio of 2.71. Calumet Specialty recorded a loss per share of 5.27. The entity last dividend was issued on the 29th of January 2016. The firm had 1:1 split on the 11th of July 2024. Calumet Specialty Products Partners, L.P. manufactures, formulates, and markets slate of specialty branded products to various consumer-facing and industrial markets in North America and internationally. The company was founded in 1916 and is headquartered in Indianapolis, Indiana. Calumet Specialty operates under Oil Gas EP classification in the United States and is traded on NASDAQ Exchange. It employs 1450 people. For more info on Calumet Specialty Products please contact Louis Borgmann at 317 328 5660 or go to https://calumet.com.Besides selling stocks to institutional investors, Calumet Specialty also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Calumet Specialty's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Calumet Specialty's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Calumet Specialty Quarterly Liabilities And Stockholders Equity |
|
Calumet Specialty Insider Trades History
About 22.0% of Calumet Specialty Products are currently held by insiders. Unlike Calumet Specialty's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Calumet Specialty's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Calumet Specialty's insider trades
Calumet Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Calumet Specialty is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Calumet Specialty Products backward and forwards among themselves. Calumet Specialty's institutional investor refers to the entity that pools money to purchase Calumet Specialty's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Charles Schwab Investment Management Inc | 2025-06-30 | 571 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 511.6 K | Alta Fundamental Advisers Llc | 2025-06-30 | 459.9 K | Ubs Group Ag | 2025-06-30 | 452.4 K | Verition Fund Managegment, Llc | 2025-06-30 | 336.4 K | Royal Bank Of Canada | 2025-06-30 | 319 K | Ubs Asset Mgmt Americas Inc | 2025-06-30 | 282.4 K | Hudson Bay Capital Management Lp | 2025-06-30 | 264.1 K | Barnett & Co Inc | 2025-06-30 | 232 K | Wasserstein Debt Opportunities Management Lp | 2025-06-30 | 5.8 M | Adams Asset Advisors Llc | 2025-06-30 | 5.4 M |
Calumet Specialty Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Calumet Specialty insiders, such as employees or executives, is commonly permitted as long as it does not rely on Calumet Specialty's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Calumet Specialty insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Calumet Specialty Outstanding Bonds
Calumet Specialty issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Calumet Specialty uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Calumet bonds can be classified according to their maturity, which is the date when Calumet Specialty Products has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US131477AV34 Corp BondUS131477AV34 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Calumet Specialty Corporate Filings
| 13th of August 2025 Other Reports | ViewVerify | |
8K | 8th of August 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 7th of August 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 13th of June 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Calumet Stock Analysis
When running Calumet Specialty's price analysis, check to measure Calumet Specialty's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calumet Specialty is operating at the current time. Most of Calumet Specialty's value examination focuses on studying past and present price action to predict the probability of Calumet Specialty's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calumet Specialty's price. Additionally, you may evaluate how the addition of Calumet Specialty to your portfolios can decrease your overall portfolio volatility.